Do PACS1 variants impeding adaptor protein binding predispose to syndromic intellectual disability?
Open Access
- 4 May 2023
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (8) , 2181-2187
Abstract
To date, PACS1‐neurodevelopmental disorder (PACS1‐NDD) has been associated with recurrent variation of Arg203 and is considered diagnostic of PACS1‐NDD, an autosomal dominant syndromic intellectual disability disorder. Although incompletely defined, the proposed disease mechanism for this variant is altered PACS1 affinity for its client proteins. Given this proposed mechanism, we hypothesized that PACS1 variants that interfere with binding of adaptor proteins might also give rise to syndromic intellectual disability. Herein, we report a proposita and her mother with phenotypic features overlapping PACS1‐NDD and a novel PACS1 variant (NM_018026.3:c.[755C > T];[=], p.(Ser252Phe)) that impedes binding of the adaptor protein GGA3 (Golgi‐associated, gamma‐adaptin ear‐containing, ARF‐binding protein 3). We hypothesize that attenuating PACS1 binding of GGA3 also gives rise to a disorder with features overlapping those of PACS1‐NDD. This observation better delineates the mechanism by which PACS1 variation predisposes to syndromic intellectual disability.Keywords
Funding Information
- National Institutes of Health
This publication has 20 references indexed in Scilit:
- Interpretable Clinical Genomics with a Likelihood Ratio ParadigmThe American Journal of Human Genetics, 2020
- The genetics of intellectual disability: advancing technology and gene editingF1000Research, 2020
- Mutation of PACS1: the milder end of the spectrumClinical Dysmorphology, 2018
- Phenotypic Spectrum of Children with Nephronophthisis and Related CiliopathiesClinical Journal of the American Society of Nephrology, 2017
- Caught in the act – protein adaptation and the expanding roles of the PACS proteins in tissue homeostasis and diseaseJournal of Cell Science, 2017
- Association of the missense variant p.Arg203Trp in PACS1 as a cause of intellectual disability and seizuresClinical Genetics, 2017
- MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapyBrain, 2013
- Recurrent De Novo Mutations in PACS1 Cause Defective Cranial-Neural-Crest Migration and Define a Recognizable Intellectual-Disability SyndromeThe American Journal of Human Genetics, 2012
- A PACS‐1, GGA3 and CK2 complex regulates CI‐MPR traffickingThe EMBO Journal, 2006
- Nonsense Mutations in ADTB3A Cause Complete Deficiency of the β3A Subunit of Adaptor Complex-3 and Severe Hermansky-Pudlak Syndrome Type 2Pediatric Research, 2002